PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100137
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100137
Middle East & Africa whole exome sequencing (WES) market is projected to register a substantial CAGR of 8.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.
Middle East & Africa whole exome sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.
On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.
On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.
On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.
On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.
On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.
Increase in the adoption of whole exome sequencing (WES)
Growing usage of targeted sequencing methods
GeneDx, LLC
Psomagen
Integrated DNA Technologies, Inc., among others.